EGFR and neoplasm: Androgen receptor (AR) and ErbB pathways are known to interact, partially overlap and converge on targets downstream of each other’s signaling cascades to promote the survival of androgen-independent cells, leading to androgen-independent PCa tumours [55, 56, 57].